Genemedicine Co., Ltd.
Records under this name other than the patents Genemedicine Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Back to Genemedicine Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,920,099 | Anti-Cancer Compositions Containing WNT Decoy Receptor Lapsed on the fee record Ended Mar 20, 2026 · High confidence | Lapsed on the fee record | Ended Mar 20, 2026 | High confidence |
| US 9,468,690 | Decorin gene delivery system and cancer treatment Term ended Term ended Feb 24, 2026 · From the USPTO record | Term ended | Term ended Feb 24, 2026 | From the USPTO record |
| US 10,046,067 | Decorin gene delivery system and cancer treatment Term ended Ended no later than Feb 24, 2026 · From the USPTO record | Term ended | Ended no later than Feb 24, 2026 | From the USPTO record |
| US 9,850,500 | Recombinant adenoviruses capable of regulating angiogenesis Lapsed on the fee record Ended Dec 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 26, 2025 | From the USPTO record |
| US 6,423,693 | Growth hormone releasing hormone expression system and methods of use, including use in animals Formerly held Term ended Term ended Jul 24, 2018 · From the USPTO record | Term ended | Term ended Jul 24, 2018 | From the USPTO record |
| US 6,410,228 | Method for the identification of synthetic cell- or tissue- specific transcriptional regulatory regions Formerly held Term ended Term ended Jul 14, 2018 · From the USPTO record | Term ended | Term ended Jul 14, 2018 | From the USPTO record |
| US 7,026,468 | Process and Equipment for Plasmid Purification Formerly held Term ended Term ended Feb 10, 2018 · Medium confidence | Term ended | Term ended Feb 10, 2018 | Medium confidence |
| US 6,103,470 | Plasmid for delivery of nucleic acids to cells and methods of use Formerly held Term ended Term ended Dec 31, 2017 · From the USPTO record | Term ended | Term ended Dec 31, 2017 | From the USPTO record |
| US 6,040,295 | Formulated nucleic acid compositions and methods of administering the same for gene therapy Formerly held Term ended Term ended Mar 21, 2017 · From the USPTO record | Term ended | Term ended Mar 21, 2017 | From the USPTO record |
| US 6,514,947 | Formulated nucleic acid compositions and methods of administering the same for gene therapy Formerly held Term ended Ended no later than Jan 13, 2015 · From the USPTO record | Term ended | Ended no later than Jan 13, 2015 | From the USPTO record |